Eli Lilly Just Added Another Potential Billion-Dollar Product: Is It a Buy?The Motley Fool • 11/03/23
Ozempic Sales Soar 56% in Q3. But Is Eli Lilly a Better Stock to Buy Than Novo Nordisk?The Motley Fool • 11/03/23
Eli Lilly sees strong 3Q sales fueled by Mounjaro but cuts profit outlookProactive Investors • 11/02/23
Lilly Announces Details of Pirtobrutinib Presentations in B-Cell Malignancies at 2023 ASH Annual MeetingPRNewsWire • 11/02/23
Eli Lilly's stock drops after surprise profit is reported but full-year outlook was slashedMarket Watch • 11/02/23
Lilly Reports Third-Quarter 2023 Financial Results, Highlights Strong Sales Growth and Business Development ActivityPRNewsWire • 11/02/23
Curious about Lilly (LLY) Q3 Performance? Explore Wall Street Estimates for Key MetricsZacks Investment Research • 11/01/23
Hip-Hop Classic "It Takes Two" Takes on New Meaning in Remix to Elevate Importance of Testing for Kidney DiseasePRNewsWire • 11/01/23
Eli Lilly Stock Has Quadrupled in 3 Years. Could a Weight-Loss Drug Approval Make It Happen Again?The Motley Fool • 10/31/23